NEJM Interviews

Latest Episodes:

NEJM Interview: Dr. Arnold Milstein on learning health systems and reducing health care spending. Jan 02, 2013

Show notes

Dr. Arnold Milstein is a professor of medicine at the Stanford School of Medicine and director of the Stanford Clinical Excellence Research Center. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. A. Milstein. Code Red and Blue - Safely Limiting Health Care's GDP Footprint. N Engl J Med 2013;368:1-3.

NEJM Interview: Dr. Bruce Chabner on shortages of generic drugs and possible solutions. Dec 26, 2012

Show notes

Dr. Bruce Chabner is a professor of medicine at Harvard Medical School and director of clinical research at the MGH Cancer Center at Massachusetts General Hospital. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. M.L. Metzger, A. Billett, and M.P. Link. The Impact of Drug Shortages on Children with Cancer - The Example of Mechlorethamine. N Engl J Med 2012;367:2461-3.

NEJM Interview: Dr. David Hunter on genomewide association studies and their potential clinical utility in common diseases. Dec 19, 2012

Show notes

Dr. David Hunter is a professor of epidemiology and nutrition at the Harvard School of Public Health. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. L. Fugger, G. McVean, and J.I. Bell. Genomewide Association Studies and Common Disease - Realizing Clinical Utility. N Engl J Med 2012;367:2370-1.

NEJM Interview: Dr. Irwin Redlener on the effects of Hurricane Sandy on New York health care and the lessons learned. Dec 12, 2012

Show notes

Dr. Irwin Redlener is the director of the National Center for Disaster Preparedness at Columbia University's Mailman School of Public Health. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. I. Redlener and M.J. Reilly. Lessons from Sandy - Preparing Health Systems for Future Disasters. N Engl J Med 2012;367:2269-71.

NEJM Interview: Dr. Jonathan Oberlander on the political future of health care in the United States. Dec 05, 2012

Show notes

Dr. Jonathan Oberlander is a professor of social medicine and of health policy and management at the University of North Carolina-Chapel Hill. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. J. Oberlander. The Future of Obamacare. N Engl J Med 2012;367:2165-7.

NEJM Interview: Dr. Ronald Bayer on the legal and policy issues related to the proposed graphic warning labels on cigarette packaging. Nov 28, 2012

Show notes

Dr. Ronald Bayer is a professor of sociomedical sciences at the Mailman School of Public Health at Columbia University. R. Bayer, L. Gostin, and D. Marcus-Toll. Repackaging Cigarettes - Will the Courts Thwart the FDA? N Engl J Med 2012;367:2065-7.

NEJM Interview: Prof. Kevin Outterson on the recent fungal meningitis outbreak and the regulation of compounding pharmacies in the United States. Nov 21, 2012

Show notes

Kevin Outterson is an associate professor of health law, bioethics, and human rights at the Boston University School of Law. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. K. Outterson. Regulating Compounding Pharmacies after NECC. N Engl J Med 2012;367:1969-72.

NEJM Interview: Robert Mechanic on the challenges and potential benefits of Medicare's new bundled-payment program. Nov 14, 2012

Show notes

Robert Mechanic is a senior fellow at the Heller School of Social Policy and Management at Brandeis University. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. R. Mechanic and C. Tompkins. Lessons Learned Preparing for Medicare Bundled Payments. N Engl J Med 2012;367:1873-5.

NEJM Interview: Dr. David Stevenson on hospice and other end-of-life care in the United States. Oct 31, 2012

Show notes

Dr. David Stevenson is an associate professor in the Department of Health Care Policy at Harvard Medical School. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. D.G. Stevenson. Growing Pains for the Medicare Hospice Benefit. N Engl J Med 2012;367:1683-5.

NEJM Interview: Dr. Jerry Avorn on the FDA's recent approval of two weight loss drugs. Oct 24, 2012

Show notes

Dr. Jerry Avorn is a professor of medicine at Harvard Medical School and chief of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women's Hospital in Boston. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. E. Colman and others. The FDA's Assessment of Two Drugs for Chronic Weight Management. N Engl J Med 2012;367:1577-9.

Our TOPPODCAST Picks

Follow Us

Stay Connected

Related Podcasts

Links

Stay Connected